Yu Z - Search Results

1

Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.

Carlucci G, Ananias HJ, Yu Z, Hoving HD, Helfrich W, Dierckx RA, Liu S, de Jong IJ, Elsinga PH. Carlucci G, et al. Among authors: yu z. Mol Pharm. 2013 May 6;10(5):1716-24. doi: 10.1021/mp3005462. Epub 2013 Apr 16. Mol Pharm. 2013. PMID: 23590837

2

(99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.

Ananias HJ, Yu Z, Dierckx RA, van der Wiele C, Helfrich W, Wang F, Yan Y, Chen X, de Jong IJ, Elsinga PH. Ananias HJ, et al. Among authors: yu z. Mol Pharm. 2011 Aug 1;8(4):1165-73. doi: 10.1021/mp200014h. Epub 2011 Jun 30. Mol Pharm. 2011. PMID: 21699202

3

Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.

Yu Z, Carlucci G, Ananias HJ, Dierckx RA, Liu S, Helfrich W, Wang F, de Jong IJ, Elsinga PH. Yu Z, et al. Amino Acids. 2013 Feb;44(2):543-53. doi: 10.1007/s00726-012-1369-9. Epub 2012 Jul 26. Amino Acids. 2013. PMID: 22833158

4

An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting.

Yu Z, Ananias HJ, Carlucci G, Hoving HD, Helfrich W, Dierckx RA, Wang F, de Jong IJ, Elsinga PH. Yu Z, et al. Curr Pharm Des. 2013;19(18):3329-41. doi: 10.2174/1381612811319180015. Curr Pharm Des. 2013. PMID: 23431995 Review.

5

Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: a first-in-man study.

Ananias HJ, Yu Z, Hoving HD, Rosati S, Dierckx RA, Wang F, Yan Y, Chen X, Pruim J, Lub-de Hooge MN, Helfrich W, Elsinga PH, de Jong IJ. Ananias HJ, et al. Among authors: yu z. Nucl Med Biol. 2013 Oct;40(7):933-8. doi: 10.1016/j.nucmedbio.2013.05.009. Epub 2013 Jul 26. Nucl Med Biol. 2013. PMID: 23891351 Free article. Clinical Trial.

6

Multimerization improves targeting of peptide radio-pharmaceuticals.

Carlucci G, Ananias HJ, Yu Z, Van de Wiele C, Dierckx RA, de Jong IJ, Elsinga PH. Carlucci G, et al. Among authors: yu z. Curr Pharm Des. 2012;18(17):2501-16. doi: 10.2174/13816128112092501. Curr Pharm Des. 2012. PMID: 22475514 Review.

7

Two ⁹⁰Y-labeled multimeric RGD peptides RGD4 and 3PRGD2 for integrin targeted radionuclide therapy.

Liu Z, Shi J, Jia B, Yu Z, Liu Y, Zhao H, Li F, Tian J, Chen X, Liu S, Wang F. Liu Z, et al. Among authors: yu z. Mol Pharm. 2011 Apr 4;8(2):591-9. doi: 10.1021/mp100403y. Epub 2011 Feb 15. Mol Pharm. 2011. PMID: 21247151

8

A novel type of dual-modality molecular probe for MR and nuclear imaging of tumor: preparation, characterization and in vivo application.

Liu S, Jia B, Qiao R, Yang Z, Yu Z, Liu Z, Liu K, Shi J, Ouyang H, Wang F, Gao M. Liu S, et al. Among authors: yu z. Mol Pharm. 2009 Jul-Aug;6(4):1074-82. doi: 10.1021/mp900143a. Mol Pharm. 2009. PMID: 19527074

9

99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.

Shi J, Jia B, Liu Z, Yang Z, Yu Z, Chen K, Chen X, Liu S, Wang F. Shi J, et al. Among authors: yu z. Bioconjug Chem. 2008 Jun;19(6):1170-8. doi: 10.1021/bc700471z. Epub 2008 May 21. Bioconjug Chem. 2008. PMID: 18491928

10

Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer.

Jia B, Liu Z, Shi J, Yu Z, Yang Z, Zhao H, He Z, Liu S, Wang F. Jia B, et al. Among authors: yu z. Bioconjug Chem. 2008 Jan;19(1):201-10. doi: 10.1021/bc7002988. Epub 2007 Dec 11. Bioconjug Chem. 2008. PMID: 18069778 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,192 results

Search Page

Filters